Trial Profile

Phase I trial investigating the pharmacokinetics of onapristone in healthy volunteers

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 10 Sep 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Onapristone (Primary)
Indications Breast cancer; Endometrial cancer
Focus Pharmacokinetics

Most Recent Events

10 Sep 2015 Results published in the Cancer Chemotherapy and Pharmacology.
21 Aug 2013 Status changed from not yet recruiting to recruiting, according to an Arno Therapeutics media release. The initiation follows Investigational Medicinal Product Dossier (IMPD) approval by French Health Authority ANSM in late July 2013.
10 Apr 2013 This trial is expected to start in the second half of 2013, according to an Arno Therapeutics media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com